A detailed history of Rock Springs Capital Management LP transactions in Dexcom Inc stock. As of the latest transaction made, Rock Springs Capital Management LP holds 524,000 shares of DXCM stock, worth $41.9 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
524,000
Previous 500,000 4.8%
Holding current value
$41.9 Million
Previous $56.7 Million 38.05%
% of portfolio
1.2%
Previous 1.76%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $1.54 Million - $2.79 Million
24,000 Added 4.8%
524,000 $35.1 Million
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $10.7 Million - $13.6 Million
-96,750 Reduced 16.21%
500,000 $56.7 Million
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $85,665 - $105,075
750 Added 0.13%
596,750 $82.8 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $905,879 - $1.49 Million
12,000 Added 2.05%
596,000 $74 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $8.05 Million - $12.9 Million
93,500 Added 19.06%
584,000 $54.5 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $1.35 Million - $1.67 Million
17,700 Added 3.74%
490,500 $39.5 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $25.1 Million - $49 Million
368,800 Added 354.62%
472,800 $35.2 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $4.45 Million - $6.15 Million
47,250 Added 83.26%
104,000 $53.2 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $1.33 Million - $1.67 Million
10,250 Added 22.04%
56,750 $30.5 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $96,039 - $128,862
900 Added 1.97%
46,500 $25.4 Million
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $2.48 Million - $3.3 Million
30,600 Added 204.0%
45,600 $19.5 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $1.27 Million - $1.57 Million
15,000 New
15,000 $5.39 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.